Trial NCT02732938

View at ClinicalTrials.gov 
Org. Study IDs: A9421018
Secondary IDs: 2015-003767-11

Last trial update was posted on 2019-02-04

MeSH Interventions

Gemcitabine Paclitaxel

MeSH Conditions

Adenocarcinoma

Other Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Stopping Reasons

Pfizer made a business-related decision on 04May2017 to terminate study based on change in portfolio prioritization, and is not due to safety or efficacy.

Limitations And Caveats

The study was terminated prematurely based on the company's change in prioritization for the portfolio and was not due to any safety concerns or regulatory interactions.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID